These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34065505)

  • 1. Gut Organoid as a New Platform to Study Alginate and Chitosan Mediated PLGA Nanoparticles for Drug Delivery.
    Davoudi Z; Peroutka-Bigus N; Bellaire B; Jergens A; Wannemuehler M; Wang Q
    Mar Drugs; 2021 May; 19(5):. PubMed ID: 34065505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradable Nanoparticles-Loaded PLGA Microcapsule for the Enhanced Encapsulation Efficiency and Controlled Release of Hydrophilic Drug.
    Ryu S; Park S; Lee HY; Lee H; Cho CW; Baek JS
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33801871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal organoids containing poly(lactic-co-glycolic acid) nanoparticles for the treatment of inflammatory bowel diseases.
    Davoudi Z; Peroutka-Bigus N; Bellaire B; Wannemuehler M; Barrett TA; Narasimhan B; Wang Q
    J Biomed Mater Res A; 2018 Apr; 106(4):876-886. PubMed ID: 29226615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4.
    Wang M; Zhang Y; Feng J; Gu T; Dong Q; Yang X; Sun Y; Wu Y; Chen Y; Kong W
    Int J Nanomedicine; 2013; 8():1141-54. PubMed ID: 23658482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTX-loaded three-layer PLGA/CS/ALG nanoparticle based on layer-by-layer method for cancer therapy.
    Wang F; Yuan J; Zhang Q; Yang S; Jiang S; Huang C
    J Biomater Sci Polym Ed; 2018 Sep; 29(13):1566-1578. PubMed ID: 29749303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface-modified PLGA nanoparticles with PEG/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: Inhibition effects enhanced and side effects reduced.
    Song X; Wang J; Xu Y; Shao H; Gu J
    Colloids Surf B Biointerfaces; 2019 Aug; 180():110-117. PubMed ID: 31030022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
    Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P
    Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP; Jain K; Jain NK
    Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iontophoretic transdermal delivery using chitosan-coated PLGA nanoparticles for positively charged drugs.
    Takeuchi I; Takeshita T; Suzuki T; Makino K
    Colloids Surf B Biointerfaces; 2017 Dec; 160():520-526. PubMed ID: 29017147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The development and mechanism studies of cationic chitosan-modified biodegradable PLGA nanoparticles for efficient siRNA drug delivery.
    Yuan X; Shah BA; Kotadia NK; Li J; Gu H; Wu Z
    Pharm Res; 2010 Jul; 27(7):1285-95. PubMed ID: 20309616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative studies on chitosan and polylactic-co-glycolic acid incorporated nanoparticles of low molecular weight heparin.
    Yang T; Nyiawung D; Silber A; Hao J; Lai L; Bai S
    AAPS PharmSciTech; 2012 Dec; 13(4):1309-18. PubMed ID: 23054983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation, in vitro and in vivo evaluation of PLGA/Chitosan based nano-complex as a novel insulin delivery formulation.
    Mohammadpour F; Hadizadeh F; Tafaghodi M; Sadri K; Mohammadpour AH; Kalani MR; Gholami L; Mahmoudi A; Chamani J
    Int J Pharm; 2019 Dec; 572():118710. PubMed ID: 31629731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes.
    Lee C; Choi JS; Kim I; Oh KT; Lee ES; Park ES; Lee KC; Youn YS
    Int J Nanomedicine; 2013; 8():2975-83. PubMed ID: 23976850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation, characterization of PLGA/chitosan nanoparticles as a delivery system for controlled release of DHA.
    Liu E; Zhao S; Li X; Meng X; Liu B
    Int J Biol Macromol; 2021 Aug; 185():782-791. PubMed ID: 34216672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of alginate coated chitosan microparticles for vaccine delivery.
    Li X; Kong X; Shi S; Zheng X; Guo G; Wei Y; Qian Z
    BMC Biotechnol; 2008 Nov; 8():89. PubMed ID: 19019229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetrac-decorated chitosan-coated PLGA nanoparticles as a new platform for targeted delivery of SN38.
    Alibolandi M; Amel Farzad S; Mohammadi M; Abnous K; Taghdisi SM; Kalalinia F; Ramezani M
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):1003-1014. PubMed ID: 29806500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of small intestinal organoids for experimental intestinal physiology.
    Capeling M; Huang S; Mulero-Russe A; Cieza R; Tsai YH; Garcia A; Hill DR
    Methods Cell Biol; 2020; 159():143-174. PubMed ID: 32586441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spray-dried chitosan microparticles for cellular delivery of an antigenic protein: physico-chemical properties and cellular uptake by dendritic cells and macrophages.
    Kusonwiriyawong C; Lipipun V; Vardhanabhuti N; Zhang Q; Ritthidej GC
    Pharm Res; 2013 Jun; 30(6):1677-97. PubMed ID: 23483441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-loaded nanoparticles are prepared by alginate ionotropic pre-gelation followed by chitosan polyelectrolyte complexation.
    Sarmento B; Ribeiro AJ; Veiga F; Ferreira DC; Neufeld RJ
    J Nanosci Nanotechnol; 2007 Aug; 7(8):2833-41. PubMed ID: 17685304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison and process optimization of PLGA, chitosan and silica nanoparticles for potential oral vaccine delivery.
    Amin MK; Boateng JS
    Ther Deliv; 2019 Aug; 10(8):493-514. PubMed ID: 31496377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.